These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 11362780)
1. A difficult case of PCP. Zuger A AIDS Clin Care; 1995 Sep; 7(9):74, 78. PubMed ID: 11362780 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ; Hauptman SP Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [TBL] [Abstract][Full Text] [Related]
3. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole. Korraa H; Saadeh C South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455 [TBL] [Abstract][Full Text] [Related]
4. Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome. Montgomery AB; Feigal DW; Sattler F; Mason GR; Catanzaro A; Edison R; Markowitz N; Johnson E; Ogawa S; Rovzar M Am J Respir Crit Care Med; 1995 Apr; 151(4):1068-74. PubMed ID: 7697233 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. Helweg-Larsen J; Benfield T; Atzori C; Miller RF J Antimicrob Chemother; 2009 Dec; 64(6):1282-90. PubMed ID: 19858161 [TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. Klein NC; Duncanson FP; Lenox TH; Forszpaniak C; Sherer CB; Quentzel H; Nunez M; Suarez M; Kawwaff O; Pitta-Alvarez A AIDS; 1992 Mar; 6(3):301-5. PubMed ID: 1567574 [TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses. May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539 [TBL] [Abstract][Full Text] [Related]
9. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review. Benfield T; Atzori C; Miller RF; Helweg-Larsen J J Acquir Immune Defic Syndr; 2008 May; 48(1):63-7. PubMed ID: 18360286 [TBL] [Abstract][Full Text] [Related]
10. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC; Rimland D Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975 [TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. Carr A; Tindall B; Penny R; Cooper DA AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714 [TBL] [Abstract][Full Text] [Related]
12. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient. Cook DE; Kossey JL Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811 [TBL] [Abstract][Full Text] [Related]
13. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257 [TBL] [Abstract][Full Text] [Related]
14. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948 [TBL] [Abstract][Full Text] [Related]
15. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group. Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152 [TBL] [Abstract][Full Text] [Related]
16. Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia. Kim T; Kim SH; Park KH; Cho OH; Sung H; Kim MN; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO J Infect Chemother; 2009 Oct; 15(5):343-6. PubMed ID: 19856077 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials. Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518 [TBL] [Abstract][Full Text] [Related]
18. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients. Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070 [TBL] [Abstract][Full Text] [Related]
19. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. al-Tawfiq JA; Sorensen SJ; Cushing HE Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]